Medication-Assisted Treatment: What the Evidence Shows
Medication-assisted treatment — now more often called medications for opioid use disorder (MOUD) or simply medication for addiction treatment — combines FDA-approved medications with counseling and behavioral therapies. Despite decades of supporting evidence, MAT remains widely misunderstood. This article explains what the medications do, what the research shows, and how to find providers in the Southeast.
The Medications and How They Work
For opioid use disorder, three medications are approved in the United States:
| Medication | Used for | How it works, in brief |
|---|---|---|
| Methadone | Opioid use disorder | A long-acting medication that reduces withdrawal and cravings; dispensed through licensed programs |
| Buprenorphine | Opioid use disorder | A partial opioid agonist that eases cravings with a ceiling on respiratory effects |
| Naltrexone | Opioid and alcohol use disorders | Blocks opioid effects and can reduce the rewarding effects of alcohol |
| Acamprosate | Alcohol use disorder | Helps stabilize brain chemistry after a person stops drinking |
| Disulfiram | Alcohol use disorder | Produces an unpleasant reaction to alcohol, supporting abstinence |
- Methadone — a long-acting opioid agonist dispensed through federally regulated opioid treatment programs. It prevents withdrawal and cravings without producing euphoria at stable doses.
- Buprenorphine — a partial agonist available by prescription from qualified clinicians, including many primary care providers. Its ceiling effect lowers overdose risk compared with full agonists.
- Naltrexone — an opioid blocker, available as a daily pill or monthly injection, that prevents opioids from producing effects. It requires full detoxification before starting.
For alcohol use disorder, approved medications include naltrexone, acamprosate, and disulfiram — each working through a different mechanism, from reducing craving to creating an aversive reaction to alcohol.
What the Evidence Shows
The research base for methadone and buprenorphine is among the strongest in addiction medicine. Large studies and systematic reviews consistently find that these medications reduce illicit opioid use, improve retention in treatment, and — most importantly — reduce overdose deaths substantially. Major medical bodies, including the National Institute on Drug Abuse, the American Society of Addiction Medicine, and the World Health Organization, endorse them as first-line treatments for opioid use disorder.
Medication works best as part of a broader plan. Counseling, peer support, stable housing, and treatment for co-occurring mental health conditions all improve outcomes. But the evidence does not support withholding medication until a person "earns" it through abstinence — for opioid use disorder, medication is often the intervention that makes everything else possible.
Addressing the Stigma
A persistent myth holds that MAT "replaces one drug with another." This confuses physical dependence — a predictable physiological state managed under medical supervision — with addiction, which is defined by compulsive use despite harm. A person stabilized on buprenorphine who works, parents, and participates in their community is in recovery by any meaningful clinical definition. Many people taper off medication eventually; others benefit from years of maintenance. Both are legitimate outcomes decided between patient and clinician.
Finding MAT Providers in the Southeast
Access has expanded considerably. Buprenorphine can now be prescribed in office-based settings without the special waiver that once limited it, and telehealth initiation has become common. Opioid treatment programs offering methadone operate in every Southeast state, concentrated in metro areas but increasingly reaching rural communities through mobile units and satellite clinics. The SAMHSA treatment locator (findtreatment.gov) filters specifically for providers offering these medications, and state health departments maintain directories of licensed opioid treatment programs.
Questions to Ask a Provider
- Which medications do you offer directly, and which by referral?
- How do you combine medication with counseling and recovery support?
- What does the induction process look like, and can it begin quickly?
- How is the decision about treatment duration made — and who makes it?
MAT is not the right fit for every person, and it is never the whole of treatment. But for opioid and alcohol use disorders, it is a well-studied, mainstream medical option — and one that saves lives at a scale few other interventions match.